EDGAR filings

Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.

EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.

Form types Filers
Clear

50 rows on this page.

Filed Form Filer Category 8-K items / description Accession
2026-09-29 20-F/A NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Financial reports FORM 20-F/A 0001640334-26-001603
2026-09-16 20-F/A NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Financial reports FORM 20-F/A 0001640334-26-001557
2026-09-14 20-F NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Financial reports FORM 20-F 0001640334-26-001515
2026-08-31 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-26-001427
2026-08-07 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-26-001291
2026-06-03 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-26-000983
2026-03-27 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-26-000562
2025-11-07 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-25-001988
2025-10-22 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-25-001864
2025-10-22 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-25-001862
2025-09-23 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-25-001701
2025-06-03 20-F NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Financial reports FORM 20-F 0001640334-25-000972
2025-05-22 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-25-000923
2025-05-01 NT 20-F NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Financial reports 0001640334-25-000728
2025-03-11 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-25-000362
2025-01-02 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-25-000006
2024-12-17 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-24-001904
2024-08-29 20-F NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Financial reports FORM 20-F 0001640334-24-001383
2024-07-18 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-24-001139
2024-07-16 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-24-001122
2024-05-13 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-24-000763
2024-03-28 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-24-000510
2023-11-15 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-002155
2023-11-09 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-002040
2023-11-06 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-002021
2023-10-26 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001964
2023-09-25 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001739
2023-09-08 25-NSE NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Other 0001354457-23-000656
2023-08-29 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001653
2023-08-14 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001575
2023-08-02 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001425
2023-07-31 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001389
2023-07-25 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001360
2023-07-25 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001358
2023-07-12 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001265
2023-07-06 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001216
2023-06-29 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001158
2023-06-29 6-K/A NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K/A 0001640334-23-001155
2023-06-27 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-001135
2023-06-26 4/A NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Ownership 0001729637-23-000006
2023-05-18 4/A NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Ownership 0001729637-23-000003
2023-05-12 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-000844
2023-05-02 20-F NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Financial reports FORM 20-F 0001640334-23-000736
2023-03-31 NT 20-F NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Financial reports 0001640334-23-000534
2023-01-06 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-23-000029
2022-11-16 6-K/A NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K/A 0001640334-22-002480
2022-11-16 6-K/A NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-KA 0001640334-22-002477
2022-11-14 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-22-002452
2022-11-14 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-22-002387
2022-08-15 6-K NYMXF
NYMOX PHARMACEUTICAL CORP
CIK 1018735
Current reports FORM 6-K 0001640334-22-001775